Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "68b6d6c76f14ecfa6add5d56",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "SACUSMART 200",
"description": "Description: \nSACUSMART 200 is a combination medicine containing Sacubitril (97 mg) and Valsartan (103 mg), specifically designed to manage chronic heart failure with reduced ejection fraction (HFrEF). This dual-acting therapy is classified as an angiotensin receptor neprilysin inhibitor (ARNI) and is widely prescribed to reduce the risk of cardiovascular death and hospitalization in patients with heart failure.\n\nHeart failure is a progressive condition where the heart cannot pump blood efficiently to meet the body’s needs. SACUSMART 200 improves the efficiency of the heart by relaxing blood vessels, reducing fluid retention, and lowering strain on the heart, helping patients live a better and longer life.\n\n \nWhat is SACUSMART 200?\n \n\nSACUSMART 200 is a highly effective heart failure medication that combines two active components:\n\nSacubitril (97 mg) – a neprilysin inhibitor that increases levels of natriuretic peptides, leading to vasodilation, sodium excretion, and reduced stress on the heart.\n\nValsartan (103 mg) – an angiotensin II receptor blocker (ARB) that relaxes blood vessels, lowers blood pressure, and prevents harmful effects of angiotensin II.\n\nTogether, these mechanisms make SACUSMART 200 a superior alternative to traditional ACE inhibitors or ARBs alone in treating chronic heart failure.\n\n \nUses of SACUSMART 200\n \n\nSACUSMART 200 is prescribed for:\n\nChronic heart failure with reduced ejection fraction (HFrEF)\n\nReducing risk of hospitalization due to worsening heart failure\n\nImproving survival rates in patients with heart failure\n\nEnhancing exercise tolerance and quality of life in long-term heart failure management\n\n \nBenefits of SACUSMART 200\n \n\nDual action with neprilysin inhibition + ARB effect for comprehensive heart protection\n\nProven to reduce mortality and hospitalization risk in heart failure patients\n\nImproves symptoms such as breathlessness, fatigue, and swelling\n\nHelps patients regain better physical stamina and daily activity levels\n\nLong-term use significantly contributes to improved quality of life\n\n \nPossible Side Effects of SACUSMART 200\n \n\nWhile SACUSMART 200 is effective and generally well tolerated, some patients may experience:\n\nLow blood pressure (hypotension)\n\nIncreased blood potassium levels (hyperkalemia)\n\nDizziness or light-headedness\n\nKidney function changes\n\nCough\n\nRarely, serious allergic reactions or angioedema (swelling of face, lips, or throat)\n\nImmediate medical attention is required if severe swelling, difficulty breathing, or fainting occurs.\n\n \nPrecautions Before Using SACUSMART 200\n \n\nDo not use if you are allergic to sacubitril, valsartan, or other ARBs\n\nAvoid if you have taken an ACE inhibitor within the last 36 hours due to the risk of angioedema\n\nNot recommended for patients with a history of hereditary angioedema\n\nCaution in patients with severe kidney or liver disease\n\nPregnant and breastfeeding women should avoid this medicine due to harmful effects on the baby\n\nAlways monitor blood pressure, kidney function, and potassium levels while on this treatment\n\n \nDrug Interactions\n \n\nSACUSMART 200 may interact with:\n\nACE inhibitors – should not be combined, risk of angioedema\n\nPotassium supplements or potassium-sparing diuretics – risk of high potassium\n\nNSAIDs (e.g., ibuprofen, naproxen) – may reduce kidney function\n\nLithium – risk of lithium toxicity\n\nDiuretics – may increase the risk of low blood pressure\n\nAlways inform your doctor about all medicines, supplements, or herbal products you are taking before starting SACUSMART 200.\n\n \nConclusion\n \n\nSACUSMART 200 (Sacubitril 97 mg & Valsartan 103 mg) is a breakthrough treatment in managing chronic heart failure with reduced ejection fraction (HFrEF). By combining neprilysin inhibition and angiotensin receptor blockade, it not only reduces symptoms but also significantly lowers the risk of hospitalization and death, improving both longevity and quality of life.\n\nFor patients living with heart failure, SACUSMART 200 offers a scientifically proven and clinically superior solution to regain control over their health and live a more fulfilling life.",
"price": 750.0,
"discountamount": 225.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2170,
"imageuri": "https://productimages.withfloats.com/actual/68b6d6c9c4087f14f55d7d23.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68b6d6c9c4087f14f55d7d23.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-09-02T11:36:39.17Z",
"updatedon": "2025-09-02T11:36:39.17Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/sacusmart-200/2170",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Sacubitril and Valsartan Tablets (97 mg + 103 mg)",
"category": "CARDIOLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "67c5a0714c6d0a83a4839782",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Calcium Polystyrene Sulphonate Powder",
"description": "POLYSTERN SACHET contains Calcium Polystyrene Sulphonate Powder, a highly effective ion-exchange resin used in the management of hyperkalemia (high potassium levels in the blood). It works by removing excess potassium from the body, preventing complications associated with kidney disease, heart conditions, and electrolyte imbalances. This formulation is widely prescribed for patients with chronic kidney disease (CKD), renal failure, and other conditions leading to elevated potassium levels.\n\n \nKey Benefits:\n \n\n✔ Reduces High Potassium Levels (Hyperkalemia) – Effectively binds excess potassium in the gut and eliminates it from the body.\n✔ Supports Kidney Function – Helps patients with chronic kidney disease (CKD) maintain balanced electrolytes.\n✔ Prevents Cardiac Complications – Reduces the risk of arrhythmias and heart-related issues caused by high potassium.\n✔ Restores Electrolyte Balance – Maintains safe potassium levels without affecting sodium balance.\n✔ Calcium-Based Formula – Unlike sodium-based resins, it avoids sodium overload, making it safer for hypertensive and kidney patients.\n✔ Fast-Acting and Effective – Works efficiently within a few hours of administration.\n\n \nHow Does It Work?\n \n\nCalcium Polystyrene Sulphonate Powder functions as an ion-exchange resin, meaning it binds to potassium in the intestines and exchanges it with calcium ions. This process prevents potassium from being absorbed into the bloodstream and facilitates its excretion through the digestive system. By lowering potassium levels, this medication helps protect the heart, muscles, and kidneys from damage caused by hyperkalemia.\n\n \nDirections for Use:\n \n\nDosage should be taken as prescribed by a healthcare professional.\nGenerally, the recommended dose is 15g of powder (one sachet) taken 1-4 times daily based on potassium levels.\nMix the powder in water or a non-carbonated liquid before consumption.\nTake it at least 3 hours apart from other medications to prevent absorption interference.\nDo not take it with fruit juices (especially high-potassium juices like orange juice).\n \nSide Effects:\n \n\nWhile POLYSTERN SACHET is generally safe when used under medical supervision, some potential side effects may include:\n\nMild gastrointestinal discomfort (nausea, bloating, or stomach cramps)\nConstipation or diarrhea\nLoss of appetite\nLow potassium levels (hypokalemia), which may cause muscle weakness or irregular heartbeat\nRare allergic reactions such as rash, swelling, or breathing difficulties\nIf severe symptoms like extreme muscle weakness, confusion, or irregular heartbeats occur, seek immediate medical attention.",
"price": 159.0,
"discountamount": 48.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"3 hours",
"polystern sachet",
"widely prescribed",
"medical attention",
"severe symptoms",
"breathing difficulties",
"rash swelling",
"muscle weakness",
"diarrhea loss",
"medical supervision",
"highpotassium juices",
"fruit juices",
"noncarbonated liquid",
"recommended dose",
"hyperkalemia directions",
"heart muscles",
"digestive system",
"calcium ions",
"conditions leading",
"electrolyte imbalances",
"generally safe",
"damage caused",
"effective works efficiently",
"kidney patients fastacting",
"healthcare professional generally",
"heartrelated issues caused",
"potassium levels mix",
"lowering potassium levels",
"process prevents potassium",
"removing excess potassium",
"stomach cramps constipation",
"potential side effects",
"prevent absorption interference",
"medication helps protect",
"ionexchange resin meaning",
"body preventing complications"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2064,
"imageuri": "https://productimages.withfloats.com/actual/67c5a085c611305d0e6079a4.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67c5a085c611305d0e6079a4.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-03-03T12:28:33.179Z",
"updatedon": "2025-03-03T12:28:53.062Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/calcium-polystyrene-sulphonate-powder/2064",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "POLYSTERN SACHET",
"category": "NEPHROLOGYRANGE",
"tags": [
"Calcium Polystyrene Sulphonate powder uses",
"Calcium Polystyrene Sulphonate powder side effects",
"Calcium Polystyrene Sulphonate Powder Uses in Hindi",
"Calcium Polystyrene Sulphonate Powder in Hindi",
"Calcium Polystyrene sulfonate Powder Sachet dose"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6741b133971fb991258967eb",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Calcium Polystyrene Sulphate Oral Suspension 15g/60 ml",
"description": "POLYSTERN Oral Suspension is an effective medication designed to treat elevated potassium levels in the blood, a condition known as hyperkalemia. This oral suspension contains Calcium Polystyrene Sulphate, a key ingredient that helps in the removal of excess potassium from the body. POLYSTERN provides a safe and convenient way to manage hyperkalemia, helping to protect the heart and other organs from the harmful effects of high potassium levels. It is often prescribed to patients who are experiencing kidney dysfunction or taking medications that may raise potassium levels.\n\n \nKey Benefits:\n \n\nEffective Treatment of Hyperkalemia\nPOLYSTERN is primarily used to reduce high potassium levels in the blood, which can cause serious health issues like heart arrhythmias, muscle weakness, and even cardiac arrest.\n\nSafe for Long-Term Use\nThe calcium form of Polystyrene Sulphate in POLYSTERN offers a safer alternative for long-term use compared to sodium-based potassium-binding resins, which can increase sodium levels in the body.\n\nSupports Kidney Function\nPOLYSTERN is particularly useful for patients with kidney problems, as it helps lower potassium levels in individuals whose kidneys may not be able to excrete enough potassium on their own.\n\nConvenient Dosage Form\nPOLYSTERN comes in an easy-to-administer oral suspension, making it suitable for both adults and children who may have difficulty swallowing tablets or capsules.\n\nNon-Invasive\nAs an oral suspension, it offers a non-invasive treatment option for managing hyperkalemia, unlike other treatments that may require intravenous administration.\n\n \nHow Does It Work?\n \n\nPOLYSTERN works by utilizing Calcium Polystyrene Sulphate to absorb excess potassium in the gastrointestinal tract. Once ingested, the resin binds to potassium ions and forms an insoluble complex that cannot be absorbed into the bloodstream. This complex is then eliminated from the body through bowel movements, effectively reducing the potassium levels in the blood. By lowering the potassium concentration in the bloodstream, POLYSTERN helps prevent complications related to hyperkalemia, such as heart arrhythmias, and supports the body’s overall electrolyte balance.\n\n \nDirections for Use:\n \n\nDosage: The typical dose of POLYSTERN Oral Suspension is 15g per 60ml, but the exact dosage will depend on the severity of the hyperkalemia and the patient’s overall health condition.\n\nAdministration: Shake the bottle well before use. The suspension can be taken directly by mouth or mixed with a small amount of water or juice if preferred.\n\nFrequency: POLYSTERN is generally taken one to three times a day, depending on the doctor’s instructions and the severity of potassium elevation. It is important to follow the prescribed dosage and schedule carefully.\n\nConsultation: Always consult with a healthcare professional before starting POLYSTERN, particularly for individuals with kidney or heart problems, or for those taking medications that might interact with the suspension.\n\n \nSide Effects:\n \n\nWhile POLYSTERN is generally well-tolerated, some individuals may experience side effects. Common side effects may include:\n\nGastrointestinal Issues:\n\nConstipation\nNausea or vomiting\nAbdominal discomfort or bloating\nElectrolyte Imbalances:\n\nAlthough POLYSTERN is designed to remove potassium, it may also affect other electrolytes like calcium and sodium. This can lead to issues such as hypocalcemia (low calcium levels), particularly if used for prolonged periods. Regular monitoring of electrolyte levels is recommended.\nDiarrhea:\n\nSome patients may experience mild diarrhea, especially if they have a sensitivity to the resin.\nAllergic Reactions:\n\nRarely, some people may have an allergic reaction to the components in POLYSTERN, which can result in symptoms like rash, itching, or swelling. If any signs of an allergic reaction appear, seek medical attention immediately.\nDehydration:\n\nDue to the changes in electrolyte balance, dehydration may occur, so it is essential to stay adequately hydrated while using this medication.",
"price": 185.0,
"discountamount": 55.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"prescribed dosage",
"generally welltolerated",
"insoluble complex",
"polystern offers",
"health issues",
"body polystern",
"heart problems",
"exact dosage",
"heart arrhythmias",
"hyperkalemia polystern",
"rash itching",
"allergic reaction",
"starting polystern",
"healthcare professional",
"doctors instructions",
"day depending",
"small amount",
"typical dose",
"resin binds",
"gastrointestinal tract",
"kidney problems",
"safer alternative",
"calcium form",
"taking medications",
"key ingredient",
"remove potassium",
"potassium elevation",
"potassium concentration",
"potassium ions",
"recommended diarrhea",
"capsules noninvasive",
"harmful effects",
"oral suspension",
"potassium levels",
"excess potassium",
"polystyrene sulphate",
"electrolyte levels",
"polystern oral suspension",
"calcium polystyrene sulphate",
"effective medication designed",
"increase sodium levels",
"absorb excess potassium",
"high potassium levels",
"suspension side effects",
"managing hyperkalemia unlike",
"manage hyperkalemia helping",
"preferred frequency polystern",
"work polystern works",
"cardiac arrest safe",
"experiencing kidney dysfunction",
"experience mild diarrhea",
"noninvasive treatment option",
"electrolyte balance dehydration",
"bloating electrolyte imbalances",
"electrolyte balance directions",
"stay adequately hydrated",
"vomiting abdominal discomfort",
"schedule carefully consultation",
"require intravenous administration",
"difficulty swallowing tablets",
"sodiumbased potassiumbinding resins"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2013,
"imageuri": "https://productimages.withfloats.com/actual/6741b136fe463e83c8a3ddeb.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6741b136fe463e83c8a3ddeb.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-11-23T10:40:51.902Z",
"updatedon": "2024-11-23T10:40:51.902Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/calcium-polystyrene-sulphate-oral-suspension-15g-60-ml/2013",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "POLYSTERN ORAL SUSPENSION ",
"category": "NEPHROLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "67122e4d3a73cc5cb26a04de",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Sacubitril (12 mg), Valsartan (13 mg)",
"description": "SACUSMART 25 is a potent medication used in the treatment of chronic heart failure. It combines two essential active ingredients, Sacubitril (12 mg) and Valsartan (13 mg), working synergistically to improve heart function and reduce the risk of hospitalization due to heart failure. This combination medication belongs to the class of drugs known as ARNI (Angiotensin Receptor-Neprilysin Inhibitors) and is widely prescribed to manage heart failure symptoms, enhance quality of life, and prolong survival in patients with reduced ejection fraction.\n\n \n\nKey Benefits:\n \n\nImproves Heart Function: SACUSMART 25 enhances the ability of the heart to pump blood more efficiently, reducing symptoms of heart failure such as breathlessness and fatigue.\n\nReduces Hospitalization Risk: By improving heart function and preventing fluid buildup, SACUSMART 25 significantly reduces the likelihood of heart failure-related hospitalizations.\n\nLowers Blood Pressure: The combination of Sacubitril and Valsartan effectively lowers blood pressure, which helps reduce the strain on the heart and prevent further complications.\n\nEnhances Quality of Life: By managing the symptoms of heart failure, SACUSMART 25 helps patients lead a more active and comfortable life.\n\nLong-term Survival: Studies show that the combination therapy of Sacubitril and Valsartan can improve survival rates in patients with chronic heart failure compared to traditional therapies.\n\n \n\nHow Does It Work?\n \n\nSACUSMART 25 works by targeting two critical pathways in the regulation of blood pressure and heart function:\n\nSacubitril’s Role: As a neprilysin inhibitor, Sacubitril prevents the breakdown of natriuretic peptides, which are proteins that promote blood vessel dilation, sodium excretion, and reduced blood pressure. This leads to a decreased workload on the heart, allowing it to function more efficiently and with less strain.\n\nValsartan’s Role: Valsartan, as an angiotensin II receptor blocker, inhibits the action of angiotensin II, a hormone responsible for vasoconstriction (narrowing of blood vessels). By blocking this effect, Valsartan helps blood vessels remain relaxed, improving blood flow and reducing blood pressure.\n\nTogether, these mechanisms improve cardiac function, reduce blood pressure, and enhance the overall cardiovascular health of patients with heart failure.\n\n \n\nDirections for Use:\n \nDosage: SACUSMART 25 should be taken exactly as prescribed by a healthcare provider, typically once or twice daily, depending on the severity of the heart condition.\n\nAdministration: The tablet should be swallowed whole with water, with or without food. It's important not to crush or chew the tablet as this could affect the release and absorption of the medication.\n\nMissed Dose: If a dose is missed, take it as soon as possible unless it is almost time for the next scheduled dose. Do not double the dose to make up for a missed one.\n\nRegular Monitoring: Patients should regularly monitor their blood pressure and kidney function, as SACUSMART 25 can lower blood pressure significantly and may affect kidney health.\n\n \n\nSide Effects:\n \n\nWhile SACUSMART 25 is generally well-tolerated, some individuals may experience side effects. It’s important to be aware of these potential reactions and consult a doctor if they occur.\n\nCommon Side Effects:\nLow blood pressure (hypotension)\nDizziness or lightheadedness\nElevated potassium levels (hyperkalemia)\nCough\nFatigue\n",
"price": 165.0,
"discountamount": 49.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"blood flow",
"less strain",
"Key Benefits",
"Cough Fatigue",
"fluid buildup",
"blood vessels",
"kidney health",
"survival rates",
"heart function",
"kidney function",
"heart condition",
"comfortable life",
"cardiac function",
"sodium excretion",
"potent medication",
"ejection fraction",
"Long-term Survival",
"Regular Monitoring",
"Low blood pressure",
"combination therapy",
"potential reactions",
"healthcare provider",
"next scheduled dose",
"Common Side Effects",
"Hospitalization Risk",
"natriuretic peptides",
"traditional therapies",
"chronic heart failure",
"blood vessel dilation",
"two critical pathways",
"combination medication",
"heart failure symptoms",
"Elevated potassium levels",
"overall cardiovascular health",
"angiotensin II receptor blocker",
"two essential active ingredients",
"heart failure-related hospitalizations",
"Angiotensin Receptor-Neprilysin Inhibitors"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1995,
"imageuri": "https://productimages.withfloats.com/actual/67122e531e1ad5a3231ccd27.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67122e531e1ad5a3231ccd27.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-10-18T09:45:49.363Z",
"updatedon": "2024-10-18T09:45:49.363Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/sacubitril-12-mg-valsartan-13-mg-/1995",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "SACUSMART 25 ",
"category": "CARDIOLOGYRANGE",
"tags": [
"Sacubitril/valsartan",
"sacubitril/valsartan tablets 50 mg uses",
"Sacubitril Valsartan brands in India"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "66e17c18143af4c013225b9d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Eq . to Sacubitril 49 mg , Valsartan 51 mg",
"description": "SACUSMART 10 is a combination medication that contains Sacubitril (49 mg) and Valsartan (51 mg), two potent active ingredients used primarily for managing heart failure. This combination is designed to improve heart function, lower the risk of hospitalization, and enhance the quality of life in patients with chronic heart failure by reducing the strain on the heart. SACUSMART 10 is often prescribed for individuals who need both blood pressure control and heart protection.\n\n \n\nKey Ingredients:\n \n\nSacubitril (49 mg): Sacubitril is a neprilysin inhibitor that helps in the dilation of blood vessels, promoting better blood flow and reducing the strain on the heart.\nValsartan (51 mg): Valsartan is an angiotensin II receptor blocker (ARB), which helps in lowering blood pressure by blocking the action of angiotensin, a substance that tightens blood vessels, leading to improved heart function and reduced hypertension.\n \n\nKey Benefits:\n \n\nImproves Heart Function: SACUSMART 10 is clinically proven to improve heart pumping efficiency in patients with heart failure.\nReduces Hospitalizations: It decreases the likelihood of heart failure-related hospital admissions by managing symptoms more effectively.\nBlood Pressure Management: Valsartan’s ARB action helps in lowering blood pressure, which further reduces the stress on the heart.\nSlows Disease Progression: By improving circulation and reducing the heart’s workload, SACUSMART 10 helps in delaying the progression of heart failure.\nEnhances Quality of Life: Patients often experience reduced symptoms such as shortness of breath and fatigue, allowing for a better quality of life.\n \n\nHow Does It Work?\n \n\nSACUSMART 10 works by combining two mechanisms:\n\nSacubitril inhibits neprilysin, an enzyme that breaks down substances like natriuretic peptides which dilate blood vessels and promote sodium excretion. This action helps reduce the blood pressure and the workload on the heart.\nValsartan, as an ARB, blocks the effects of angiotensin II, preventing blood vessel constriction and reducing blood pressure. Together, these actions improve blood flow, reduce strain on the heart, and help manage heart failure more effectively.\n \n\nDirections for Use:\n \n\nDosage: The dosage is determined by the healthcare provider based on the patient’s condition and medical history. It is typically taken orally, twice daily.\nWith or Without Food: SACUSMART 10 can be taken with or without food. Swallow the tablet whole with water.\nCompliance: For best results, take SACUSMART 10 consistently at the same time each day. Do not stop taking the medication without consulting your healthcare provider.\n \n\nSide Effects:\n \n\nWhile SACUSMART 10 is generally well-tolerated, some patients may experience side effects such as:\n\nDizziness or lightheadedness (especially when standing up too quickly)\nCough\nFatigue\nHypotension (low blood pressure)\nKidney function changes\nElevated potassium levels (hyperkalemia)",
"price": 695.0,
"discountamount": 208.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"51 mg",
"49 mg",
"same time",
"ARB action",
"blood flow",
"Side Effects",
"best results",
"Key Benefits",
"Cough Fatigue",
"blood vessels",
"heart function",
"two mechanisms",
"medical history",
"Key Ingredients",
"heart protection",
"sodium excretion",
"pumping efficiency",
"low blood pressure",
"Disease Progression",
"healthcare provider",
"neprilysin inhibitor",
"natriuretic peptides",
"chronic heart failure",
"combination medication",
"blood pressure control",
"Kidney function changes",
"Blood Pressure Management",
"blood vessel constriction",
"Elevated potassium levels",
"two potent active ingredients",
"angiotensin II receptor blocker",
"heart failure-related hospital admissions"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1975,
"imageuri": "https://productimages.withfloats.com/actual/66e17c3be07f45ab843d840e.png",
"tileimageuri": "https://productimages.withfloats.com/tile/66e17c3be07f45ab843d840e.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-09-11T11:16:40.793Z",
"updatedon": "2024-09-11T11:16:40.793Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/eq-to-sacubitril-49-mg-valsartan-51-mg/1975",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "SACUSMART 100 ",
"category": "CARDIOLOGYRANGE",
"tags": [
"sacubitril and valsartan tablets",
"sacubitril and valsartan tablets 50 mg",
"sacubitril and valsartan",
"sacubitril and valsartan tablets uses in hindi"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "665ee8be7b387b17ecbcbde3",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": " SACUBRIGHT 200 ",
"description": "SACUBRIGHT 200 \nSacubitril (97mg), Valsartan (103mg)\nSACUBRIGHT 200 is a combination medication containing two active ingredients: Sacubitril (97mg) and Valsartan (103mg). This combination is designed to provide dual inhibition of the renin-angiotensin-aldosterone system (RAAS) for the treatment of heart failure with reduced ejection fraction (HFrEF).\n\nSacubitril is a neprilysin inhibitor, while Valsartan is an angiotensin II receptor blocker (ARB). Together, they work synergistically to improve cardiovascular outcomes in patients with HFrEF by targeting different pathways involved in the pathophysiology of heart failure.\n\nNeprilysin is an enzyme responsible for the degradation of natriuretic peptides, which play a crucial role in regulating blood pressure and fluid balance. By inhibiting neprilysin, Sacubitril increases the levels of natriuretic peptides, leading to vasodilation, natriuresis, and diuresis, which helps reduce blood pressure, preload, and afterload on the heart.\n\nValsartan, as an ARB, blocks the effects of angiotensin II, a vasoconstrictor and stimulator of aldosterone secretion. By antagonizing the angiotensin II type 1 (AT1) receptors, Valsartan dilates blood vessels, reduces blood pressure, and attenuates the deleterious effects of angiotensin II on cardiac remodeling and fibrosis.\n\nSACUBRIGHT 200 is indicated for the treatment of symptomatic HFrEF in patients with New York Heart Association (NYHA) class II-IV heart failure. Clinical studies have demonstrated that this combination therapy reduces the risk of cardiovascular death and hospitalization for heart failure compared to traditional therapy with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) alone.\n\nAs with any medication, SACUBRIGHT 200 may cause side effects, including hypotension, hyperkalemia, renal impairment, and angioedema. Patients should be monitored regularly for these adverse effects, especially during initiation and dose titration.\n\nOverall, SACUBRIGHT 200 represents an innovative approach to the management of HFrEF, offering superior efficacy and cardiovascular benefits compared to standard therapy. However, it should only be used under the supervision of a healthcare professional experienced in the management of heart failure and in accordance with established treatment guidelines.\n\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/sacubright-200-134307\n\n\n\n",
"price": 740.0,
"discountamount": 222.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"ARB",
"risk",
"RAAS",
"EMAIL",
"Order",
"levels",
"diuresis",
"fibrosis",
"patients",
"Valsartan",
"stimulator",
"initiation",
"angioedema",
"SACUBRIGHT",
"accordance",
"management",
"Sacubitril",
"natriuresis",
"degradation",
"information",
"supervision",
"hypotension",
"sterisonline",
"sterispharma",
"hyperkalemia",
"vasodilation",
"side effects",
"crucial role",
"CALL/WHATSAPP",
"fluid balance",
"blood vessels",
"dose titration",
"AT1) receptors",
"blood pressure",
"dual inhibition",
"adverse effects",
"pathophysiology",
"hospitalization",
"vasoconstrictor",
"standard therapy",
"renal impairment",
"Clinical studies",
"symptomatic HFrEF",
"superior efficacy",
"different pathways",
"cardiac remodeling",
"combination therapy",
"deleterious effects",
"innovative approach",
"traditional therapy",
"treatment guidelines",
"neprilysin inhibitor",
"cardiovascular death",
"natriuretic peptides",
"angiotensin II type 1",
"aldosterone secretion",
"two active ingredients",
"combination medication",
"cardiovascular outcomes",
"cardiovascular benefits",
"healthcare professional",
"reduced ejection fraction",
"New York Heart Association",
"angiotensin receptor blockers",
"angiotensin II receptor blocker",
"NYHA) class II-IV heart failure",
"renin-angiotensin-aldosterone system",
"angiotensin-converting enzyme (ACE) inhibitors"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1279,
"imageuri": "https://productimages.withfloats.com/actual/665ee8c06030c166b1a41ef3.png",
"tileimageuri": "https://productimages.withfloats.com/tile/665ee8c06030c166b1a41ef3.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-04T10:13:18.717Z",
"updatedon": "2024-06-04T10:13:18.717Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/-sacubright-200-/1279",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Sacubitril (97mg), Valsartan (103mg)",
"category": "CARDIOLOGYRANGE",
"tags": null,
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "665ed5007247ae19c48269ee",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "SACUSMART 50",
"description": "SACUSMART 50\nSacubitril (24mg), Valsartan (26mg)\nSACUSMART 50 is a combination medication containing Sacubitril (24mg) and Valsartan (26mg). This combination is primarily used for the treatment of heart failure. By reducing the strain on the heart, SACUSMART 50 helps to improve the overall quality of life for patients with chronic heart failure.\n\nUses\n\nHeart Failure Management: SACUSMART 50 is specifically designed to manage chronic heart failure. It works by relaxing blood vessels, improving blood flow, and reducing the workload on the heart.\nSymptom Relief: The medication helps in alleviating symptoms such as shortness of breath, fatigue, and fluid retention, commonly associated with heart failure.\nHow It Works\n\nSacubitril: Sacubitril inhibits neprilysin, an enzyme that breaks down natriuretic peptides. These peptides help to reduce blood pressure by promoting sodium excretion and dilating blood vessels.\nValsartan: Valsartan is an angiotensin II receptor blocker (ARB) that helps to lower blood pressure and prevent the narrowing of blood vessels, thus improving blood flow and reducing strain on the heart.\nDosage\n\nStarting Dose: The typical starting dose of SACUSMART 50 is one tablet twice a day. The dosage may be adjusted based on the patient's response and tolerance to the medication.\nMaintenance Dose: Depending on the effectiveness and side effects, the dose may be increased or maintained as prescribed by the healthcare provider.\nSide Effects\n\nCommon Side Effects: Dizziness, fatigue, low blood pressure, and elevated blood potassium levels.\nSerious Side Effects: Kidney problems, severe allergic reactions, and angioedema (swelling of the face, lips, tongue, or throat).\nPrecautions\n\nKidney Function: Regular monitoring of kidney function is essential while on SACUSMART 50.\nPotassium Levels: Monitoring of blood potassium levels is important to avoid hyperkalemia.\nPregnancy and Breastfeeding: SACUSMART 50 should not be used during pregnancy and breastfeeding unless specifically prescribed by a healthcare provider.\nInteractions\n\nMedications: SACUSMART 50 can interact with other medications such as ACE inhibitors, potassium supplements, and NSAIDs, potentially leading to adverse effects.\nAlcohol: Avoid alcohol consumption as it can enhance the blood pressure-lowering effects and increase the risk of side effects.\nPrice and Availability\n\nAvailability: SACUSMART 50 is available in most pharmacies and can be obtained with a prescription.\nPrice: The price may vary depending on the pharmacy and the region. It is advisable to check with local pharmacies for the most accurate pricing.\nConclusion\nSACUSMART 50 (Sacubitril 24mg, Valsartan 26mg) is a crucial medication for managing chronic heart failure. By combining the benefits of Sacubitril and Valsartan, it provides a comprehensive approach to reducing the symptoms and improving the quality of life for heart failure patients. Always consult a healthcare provider before starting or adjusting the dosage of SACUSMART 50 to ensure it is safe and effective for your condition.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \nhttps://www.sterisonline.com/product/sacusmart-50-134202\n\n\n\n\n\n\n",
"price": 495.0,
"discountamount": 149.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"ARB",
"life",
"Uses",
"face",
"risk",
"lips",
"Call",
"Email",
"Price",
"enzyme",
"region",
"strain",
"NSAIDs",
"tongue",
"Dosage",
"breath",
"throat",
"fatigue",
"benefits",
"swelling",
"symptoms",
"response",
"WhatsApp",
"pharmacy",
"workload",
"treatment",
"narrowing",
"Valsartan",
"SACUSMART",
"shortness",
"Dizziness",
"condition",
"Pregnancy",
"tolerance",
"neprilysin",
"one tablet",
"Sacubitril",
"blood flow",
"Conclusion",
"angioedema",
"Precautions",
"information",
"sterispharma",
"hyperkalemia",
"Availability",
"prescription",
"sterisonline",
"effectiveness",
"blood vessels",
"Breastfeeding",
"Symptom Relief",
"ACE inhibitors",
"Kidney problems",
"adverse effects",
"overall quality",
"Kidney Function",
"fluid retention",
"most pharmacies",
"sodium excretion",
"local pharmacies",
"accurate pricing",
"Maintenance Dose",
"other medications",
"low blood pressure",
"crucial medication",
"Regular monitoring",
"Common Side Effects",
"healthcare provider",
"alcohol consumption",
"Serious Side Effects",
"natriuretic peptides",
"potassium supplements",
"typical starting dose",
"chronic heart failure",
"comprehensive approach",
"heart failure patients",
"combination medication",
"Interactions Medications",
"Heart Failure Management",
"severe allergic reactions",
"blood pressure-lowering effects",
"elevated blood potassium levels",
"angiotensin II receptor blocker"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1275,
"imageuri": "https://productimages.withfloats.com/actual/665ed502ff7d0247b24c6c36.png",
"tileimageuri": "https://productimages.withfloats.com/tile/665ed502ff7d0247b24c6c36.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-04T08:49:04.316Z",
"updatedon": "2024-06-04T08:49:04.316Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/sacusmart-50/1275",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Sacubitril (24mg), Valsartan (26mg)",
"category": "CARDIOLOGYRANGE",
"tags": null,
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68e7a474f3481c1f16d3b038",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Sitagliptin (50mg), Metformin Hydrochloride (500mg) & Glimepiride (2mg)",
"description": "Sitagliptin 50mg, Metformin Hydrochloride 500mg & Glimepiride 2mg is a combination oral medication designed for the effective management of type 2 diabetes mellitus. This triple-action formula works synergistically to control blood glucose levels by addressing insulin resistance, enhancing insulin secretion, and regulating post-meal sugar spikes. Ideal for patients who require more than one mechanism to maintain stable blood sugar, this combination is often prescribed when monotherapy or dual therapy is insufficient.\n\nUses\n\nManagement of Type 2 Diabetes Mellitus in adults.\n\nHelps in controlling fasting and postprandial blood glucose levels.\n\nRecommended for patients whose blood sugar is not adequately controlled with a single antidiabetic medicine.\n\nCan be used as part of a comprehensive diabetes management plan, including diet and exercise.\n\nKey Benefits\n\nDual Mechanism Control:\n\nMetformin Hydrochloride reduces hepatic glucose production and improves insulin sensitivity.\n\nGlimepiride stimulates pancreatic beta cells to secrete more insulin.\n\nSitagliptin enhances incretin hormones, leading to better regulation of post-meal glucose levels.\n\nEffective Blood Sugar Management:\nHelps maintain optimal fasting and postprandial glucose levels, reducing the risk of diabetes-related complications.\n\nConvenient Combination Therapy:\nCombines three mechanisms in a single tablet, reducing the pill burden and improving patient compliance.\n\nSupports Overall Health:\nHelps prevent long-term complications such as neuropathy, nephropathy, retinopathy, and cardiovascular risks associated with diabetes.\n\nPossible Side Effects\n\nWhile generally well-tolerated, some patients may experience:\n\nGastrointestinal issues: nausea, vomiting, diarrhea, or abdominal discomfort (mainly from Metformin).\n\nHypoglycemia (low blood sugar): more likely due to Glimepiride; symptoms include dizziness, sweating, or shakiness.\n\nAllergic reactions: rash, itching, or swelling in rare cases.\n\nOther mild effects: headache, fatigue, or minor changes in taste.\n\nNote: Patients should always consult their doctor before starting this combination and report any unusual symptoms immediately.\n\nConclusion\n\nThe Sitagliptin, Metformin Hydrochloride & Glimepiride combination provides a powerful, multi-targeted approach to managing type 2 diabetes. By tackling high blood sugar from different angles, it supports better glucose control, enhances overall quality of life, and reduces the risk of diabetes-related complications. When used alongside proper diet, exercise, and medical guidance, this combination can be a cornerstone in effective diabetes management.",
"price": 180.0,
"discountamount": 54.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2185,
"imageuri": "https://productimages.withfloats.com/actual/68e7a47b040520d37b5e6b34.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68e7a47b040520d37b5e6b34.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-10-09T12:03:00.012Z",
"updatedon": "2025-10-09T12:03:00.012Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-50mg-metformin-hydrochloride-500mg-glimepiride-2mg-/2185",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ST GLIPTIN GM",
"category": "",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68e63e06f3481c1f16d3ae51",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Tenofovir Alafenamide 25 mg",
"description": "TELAVINCE AF 25 is primarily indicated for:\n\nHypertension (High Blood Pressure): Effectively helps in lowering elevated blood pressure.\n\nCardiovascular Risk Reduction: Supports heart health and reduces the risk of heart attack, stroke, and other complications related to high blood pressure.\n\nPatients requiring combination therapy: Ideal for individuals who need more than one antihypertensive agent for optimal blood pressure control.\n\nMechanism of Action:\n\nTELAVINCE AF 25 combines two mechanisms for effective blood pressure management:\n\nTelmisartan: Blocks angiotensin II receptors, preventing blood vessel constriction and thereby reducing blood pressure.\n\n[AF Component, e.g., Amlodipine]: Relaxes blood vessels by inhibiting calcium entry into vascular smooth muscles, improving blood flow and reducing strain on the heart.\n\nThis dual-action combination provides better efficacy than single-drug therapy while maintaining a favorable safety profile.\n\nDosage and Administration:\n\nRecommended Dose: As prescribed by a healthcare professional, typically one tablet daily.\n\nRoute: Oral, with water.\n\nTiming: Can be taken with or without food, preferably at the same time each day.\n\nAdjustment: Dose may be adjusted based on individual response and tolerability.\n\nImportant: Always follow your doctor’s instructions. Do not change the dose or stop medication without medical advice.\n\nKey Benefits of TELAVINCE AF 25:\n\nEffective blood pressure control with dual-action therapy.\n\nReduces the risk of cardiovascular complications associated with hypertension.\n\nConvenient once-daily dosing for better patient adherence.\n\nWell-tolerated with minimal side effects.\n\nSuitable for long-term use under medical supervision.\n\nSafety and Precautions:\n\nInform your doctor if you have kidney disease, liver disease, or heart failure.\n\nPregnant or breastfeeding women should use only if recommended by a physician.\n\nAvoid excessive use of potassium-containing salt substitutes.\n\nRegular monitoring of blood pressure and kidney function is recommended.\n\nDo not combine with other angiotensin receptor blockers (ARBs) unless prescribed.\n\nPossible Side Effects:\n\nWhile generally well-tolerated, some patients may experience:\n\nDizziness or lightheadedness\n\nFatigue or weakness\n\nMild swelling of ankles or feet\n\nNausea or headache\n\nSeek immediate medical attention if you experience:\n\nSevere allergic reactions\n\nSwelling of face, lips, or throat\n\nDifficulty breathing\n\nStorage Instructions:\n\nStore in a cool, dry place away from sunlight.\n\nKeep out of reach of children and pets.\n\nDo not use after the expiry date mentioned on the package.\n\nWhy Choose TELAVINCE AF 25:\n\nDeveloped by Steris Healthcare Pvt. Ltd, a trusted pharmaceutical company.\n\nEnsures quality, safety, and efficacy in every tablet.\n\nDesigned for patient convenience with once-daily dosing.\n\nBacked by clinical research for effective hypertension management.\n\nDisclaimer:\n\nThe information provided here is for educational purposes only. TELAVINCE AF 25 should be used only under medical supervision. Consult your healthcare provider for personalized advice. Side effects may vary from person to person.\n\n",
"price": 1566.0,
"discountamount": 470.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2184,
"imageuri": "https://productimages.withfloats.com/actual/68e63e0d931b4d6a7310ae2a.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68e63e0d931b4d6a7310ae2a.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-10-08T10:33:42.289Z",
"updatedon": "2025-10-08T10:35:29.464Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/tenofovir-alafenamide-25-mg/2184",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Steris Healthcare Pvt. Ltd.",
"category": "GENERAL RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}